Study to Establish the Diagnostic Performance of 18F Fluciclovine PET in Detecting Recurrent Brain Metastases
Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
An open-label, single dose, single arm, prospective, multicenter Phase 3 study to establish
the diagnostic performance of 18F fluciclovine positron emission tomography (PET) in
detecting recurrent brain metastases after radiation therapy